January 13, 2012
USADA announced today that Nick Brandt-Sorenson of Los Angeles, Calif., an athlete in the sport of cycling, has accepted a two-year suspension for an anti-doping rule violation.
Brandt-Sorenson, 32, tested positive for Efaproxiral, which artificially enhances delivery of oxygen to the tissues, as the result of a sample collected at the Masters Road Nationals in Bend, Ore. Efaproxiral is prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (UCI) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code.
Brandt-Sorenson accepted a two-year period of ineligibility, which began on September 4, 2011, the day his sample was collected. As a result of the sanction, Brandt-Sorenson is also disqualified from all competitive results obtained on or subsequent to August 31, 2011, the date the Masters Road Nationals event began, including forfeiture of any medals, points, and prizes.
In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.